Alnylam Pharmaceuticals
ALNY
#554
Rank
โ‚ฌ37.30 B
Marketcap
282,35ย โ‚ฌ
Share price
0.77%
Change (1 day)
6.28%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company